GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (FRA:SBX) » Definitions » Interest Coverage

SynBiotic SE (FRA:SBX) Interest Coverage : N/A (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. SynBiotic SE's Operating Income for the six months ended in Dec. 2023 was €0.00 Mil. SynBiotic SE's Interest Expense for the six months ended in Dec. 2023 was €0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for SynBiotic SE's Interest Coverage or its related term are showing as below:


FRA:SBX's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 11.83
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


SynBiotic SE Interest Coverage Historical Data

The historical data trend for SynBiotic SE's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

SynBiotic SE Interest Coverage Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial No Debt - - - -

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Interest Coverage Get a 7-Day Free Trial Premium Member Only - - - - N/A

Competitive Comparison of SynBiotic SE's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, SynBiotic SE's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynBiotic SE's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SynBiotic SE's Interest Coverage distribution charts can be found below:

* The bar in red indicates where SynBiotic SE's Interest Coverage falls into.


;
;

SynBiotic SE Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SynBiotic SE's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, SynBiotic SE's Interest Expense was €-0.20 Mil. Its Operating Income was €-11.00 Mil. And its Long-Term Debt & Capital Lease Obligation was €2.89 Mil.

SynBiotic SE did not have earnings to cover the interest expense.

SynBiotic SE's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, SynBiotic SE's Interest Expense was €0.00 Mil. Its Operating Income was €0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was €2.89 Mil.

GuruFocus does not calculate SynBiotic SE's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


SynBiotic SE  (FRA:SBX) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


SynBiotic SE Interest Coverage Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


SynBiotic SE Business Description

Traded in Other Exchanges
N/A
Address
Barer Strasse 7, Munich, BY, DEU, 80333
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.

SynBiotic SE Headlines

No Headlines